Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2000 1
2002 1
2003 5
2004 3
2005 6
2006 11
2007 7
2008 8
2009 15
2010 11
2011 6
2012 10
2013 10
2014 12
2015 13
2016 4
2017 10
2018 4
2019 8
2020 5
2021 2
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26109470

139 results

Results by year

Filters applied: . Clear all
Page 1
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Gyberg V, De Bacquer D, De Backer G, Jennings C, Kotseva K, Mellbin L, Schnell O, Tuomilehto J, Wood D, Rydén L, Amouyel P, Bruthans J, Conde AC, Cifkova R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pająk A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D; EUROASPIRE Investigators. Gyberg V, et al. Cardiovasc Diabetol. 2015 Oct 1;14:133. doi: 10.1186/s12933-015-0296-y. Cardiovasc Diabetol. 2015. PMID: 26427624 Free PMC article.
Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.
Fadini GP, Frison V, Simioni N, Lapolla A, Gatti A, Bossi AC, Del Buono A, Fornengo P, Gottardo L, Laudato M, Perseghin G, Bonora E, Avogaro A. Fadini GP, et al. J Am Heart Assoc. 2019 Jul 16;8(14):e012244. doi: 10.1161/JAHA.119.012244. Epub 2019 Jul 4. J Am Heart Assoc. 2019. PMID: 31269877 Free PMC article.
Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary care.
Yajima K, Shimada A, Hirose H, Oikawa Y, Yamada S, Meguro S, Irie J, Irie S. Yajima K, et al. Clin Drug Investig. 2009;29(12):811-9. doi: 10.2165/11530610-000000000-00000. Clin Drug Investig. 2009. PMID: 19888787
Effect of intensive multifactorial treatment compared with routine care on aortic stiffness and central blood pressure among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study.
Johansen NB, Charles M, Vistisen D, Rasmussen SS, Wiinberg N, Borch-Johnsen K, Lauritzen T, Sandbæk A, Witte DR. Johansen NB, et al. Diabetes Care. 2012 Nov;35(11):2207-14. doi: 10.2337/dc12-0176. Epub 2012 Jul 11. Diabetes Care. 2012. PMID: 22787176 Free PMC article. Clinical Trial.
139 results